The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II study of pazopanib with oral topotecan in patients with metastatic and non-resectable soft tissue and bone sarcomas.
 
Mark Agulnik
Consulting or Advisory Role - Eisai; Janssen; Lilly; Novartis
Speakers' Bureau - Bristol-Myers Squibb; Eisai; Janssen
 
Nisha Anjali Mohindra
Consulting or Advisory Role - AstraZeneca; Genentech/Roche
Travel, Accommodations, Expenses - AstraZeneca
 
Mohammed M. Milhem
Consulting or Advisory Role - Bristol-Myers Squibb; Eisai; EMD Serono; Genentech/Roche; Novartis
 
Steven Attia
Research Funding - AB Science (Inst); Bayer (Inst); Bayer (Inst); CytRx Corporation (Inst); Daiichi Sankyo (Inst); Dicephera Pharmaceuticals, Inc. (Inst); Epizyme (Inst); Immune Design (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Novartis (Inst); Novartis (Inst); TRACON Pharma (Inst)
Travel, Accommodations, Expenses - Immune Design
 
Steven Ian Robinson
Honoraria - BTG
Research Funding - Tricon Pharmaceuticals
Travel, Accommodations, Expenses - Tricon Pharmaceuticals
 
Alfred Rademaker
Research Funding - Siemens (Inst)
Other Relationship - Georgetown Univ.; JAMA-Journal of the American Medical Association
 
Susan E. Abbinanti
No Relationships to Disclose
 
Rasima Cehic
No Relationships to Disclose
 
Catherine Humphreys
No Relationships to Disclose
 
Bethany Prudner
No Relationships to Disclose
 
Scott H. Okuno
No Relationships to Disclose
 
Brian Andrew Van Tine
Consulting or Advisory Role - Caris Life Sciences; CytRx Corporation; EMD Serono; Johnson & Johnson; Lilly/ImClone; Novartis; Plexxikon; Threshold Pharmaceuticals
Speakers' Bureau - Caris Life Sciences; Johnson & Johnson; Lilly; Novartis
Research Funding - Merck; Pfizer
Expert Testimony - Me1 Patient